Target intelligence / Profile preview

Nucleoside

Molecular classification
Other
01

Overview

A nucleoside is a molecule composed of a nitrogenous base (purine or pyrimidine) linked to a five-carbon sugar (ribose or deoxyribose)[1][5][7]. Nucleobases, sometimes called nitrogenous bases or nucleotide bases, are the pure base moieties—adenine, guanine, cytosine, thymine, and uracil[3][9]. Nucleosides are precursors for nucleotides, which are essential for the synthesis of DNA and RNA and serve critical roles in cell signaling, energy metabolism, and as molecular drugs. Nucleoside and nucleotide analogues are clinically significant as antiviral and anticancer agents, working through incorporation into nucleic acids or inhibition of polymerase enzymes[7]. The entry "Nucleosides and nucleobases" is too broad for a meaningful target definition as a drug target; individual nucleosides or nucleotide-processing enzymes (e.g., thymidine kinase, ribonucleotide reductase) are the proper entities for therapeutic targeting. Key note: - "Nucleosides and nucleobases" is not a single drug target; it refers to broad molecular classes and should not be classified as a discrete therapeutic target or receptor[7][2]. Specific analogues/drugs act on or mimic individual nucleosides/nucleotides[7]. - For structured drug target databases, specify individual nucleosides (e.g., adenosine), nucleobases (e.g., cytosine), or relevant enzymes (e.g., thymidine kinase) instead.

Other names
NucleosidesNucleobaseNucleobasesNitrogenous baseNucleotide baseNucleosides and nucleobases
02

Mechanism of action

Inhibition of DNA/RNA synthesis (chain termination or faulty incorporation); Inhibition of viral DNA polymerase or reverse transcriptase; Interference with nucleotide metabolism

03

Biological functions

Precursor of nucleic acidsGenetic information storageGenetic information transmissionCell signalingPrecursor for nucleotide synthesis
04

Disease associations

CancerViral infectionOther (as synthetic analogues/drugs)
05

Safety considerations

Myelosuppression (especially with nucleoside analogues)Mitochondrial toxicityOff-target effects due to interference with cellular DNA/RNA synthesis
06

Interacting drugs

Nucleoside analogues (such as cytarabine, gemcitabine, zidovudine, acyclovir)

1 more in the full profile.

Beyond the preview

Go deeper on Nucleoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleoside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call